Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03968393Phase 4Recruiting
Phase 4, randomised, open-label trial in stroke and systemic embolism, sponsored by Population Health Research Institute. Primary endpoint: Incidence of Non-hemorrhagic stroke or systemic embolism at 24 months. Started Jun 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03968393.